Time-Cap Labs Overview
- Founded
-
1979

- Status
-
Acquired/Merged
- Employees
-
58

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Time-Cap Labs General Information
Description
Manufacturer of solid-dosage generic drugs based in Farmingdale, New York. The company offers a range of solid oral dosages in the form of tablets, hard gelatin capsules, soft gelatin capsules and soft gels across multiple therapeutic categories, thereby helping pharmacies increase profits with a store brand that entices customers with cost savings and creates consumer loyalty.
Contact Information
Website
www.timecaplabs.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- 7 Michael Avenue
- Farmingdale, NY 11735
- United States
+1 (631) 000-0000
Time-Cap Labs Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Time-Cap Labs Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer of solid-dosage generic drugs based in Farmingdale, New York. The company offers a range of solid oral dosa
Pharmaceuticals
Farmingdale, NY
58
As of 2023
000
0000-00-00
000000&0
Time-Cap Labs Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | 00 | |||
00000000 | Corporation | Berkeley Heights, NJ | 00 | 000.00 | 0000000000 | 000.00 |
000000000000000 00 | Corporate Backed or Acquired | Gurugram, India | 0000 | 000000&0 |
Time-Cap Labs Patents
Time-Cap Labs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-5683718-A | Uniformity; embossing | Inactive | 04-Apr-1995 | 000000000 |
Time-Cap Labs Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Joseph Errigo | President | ||
James Carroll | Chief Financial Officer |